mRNA |
navitoclax:piperlongumine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.08 |
0.04 |
mRNA |
SMER-3 |
CTRPv2 |
pan-cancer |
AAC |
0.084 |
0.04 |
mRNA |
NPK76-II-72-1 |
GDSC1000 |
pan-cancer |
AAC |
0.067 |
0.05 |
mRNA |
BRD-K88742110 |
CTRPv2 |
pan-cancer |
AAC |
-0.081 |
0.05 |
mRNA |
L-685458 |
CCLE |
pan-cancer |
AAC |
-0.099 |
0.05 |
mRNA |
triptolide |
CTRPv2 |
pan-cancer |
AAC |
-0.078 |
0.05 |
mRNA |
simvastatin |
CTRPv2 |
pan-cancer |
AAC |
0.087 |
0.05 |
mRNA |
dinaciclib |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.05 |
mRNA |
tanespimycin:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.082 |
0.05 |
mRNA |
JQ-1:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.074 |
0.05 |